Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects

NCT00514904 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1504

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal
Meningococcal Vaccines

Interventions

BIOLOGICAL: Nimenrix
BIOLOGICAL: Mencevax

Sponsor

GlaxoSmithKline